Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | RTW INVESTMENTS LP | 6,029,700 9.200% | 161,374![]() (+2.75%) | Filing History |
| 2022-02-14 08:56 am Sale | 2021-12-31 | 13G | EXAGEN INC XGN | RTW INVESTMENTS LP | 821,414 5.100% | -428,717![]() (-34.29%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | RTW INVESTMENTS LP | 2,863,198 5.600% | 2,863,198![]() (New Position) | Filing History |
| 2022-02-14 08:53 am Purchase | 2021-12-31 | 13G | ASLAN PHARMACEUTICALS LTD ADS ASLN | RTW INVESTMENTS LP | 406,250 6.800% | 406,250![]() (New Position) | Filing History |
| 2022-02-14 08:51 am Purchase | 2021-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | RTW INVESTMENTS LP | 2,120,760 6.500% | 2,120,760![]() (New Position) | Filing History |
| 2022-02-14 08:50 am Purchase | 2021-12-31 | 13G | MACROGENICS INC MGNX | RTW INVESTMENTS LP | 3,975,554 6.500% | 3,975,554![]() (New Position) | Filing History |
| 2022-02-14 08:48 am Purchase | 2021-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RTW INVESTMENTS LP | 755,482 7.700% | 32,746![]() (+4.53%) | Filing History |
| 2022-02-14 08:47 am Purchase | 2021-12-31 | 13G | CUTERA INC CUTRQ | RTW INVESTMENTS LP | 1,397,063 7.800% | 21,400![]() (+1.56%) | Filing History |
| 2022-02-14 08:46 am Sale | 2021-12-31 | 13G | ESSA PHARMA INC EPIX | RTW INVESTMENTS LP | 2,637,192 6.000% | -391,527![]() (-12.93%) | Filing History |
| 2022-02-14 08:45 am Purchase | 2021-12-31 | 13G | OYSTER PT PHARMA INC OYST | RTW INVESTMENTS LP | 2,058,504 7.900% | 132,910![]() (+6.90%) | Filing History |
| 2022-02-14 08:44 am Sale | 2021-12-31 | 13G | CLEARSIDE BIOMEDICAL INC CLSD | RTW INVESTMENTS LP | 253,735 6.400% | -10,140![]() (-3.84%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | RELMADA THERAPEUTICS INC P RLMD | RTW INVESTMENTS LP | 2,186,324 7.900% | 673,651![]() (+44.53%) | Filing History |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | IDEAYA BIOSCIENCES INC IDYA | RTW INVESTMENTS LP | 2,520,076 6.500% | 423,233![]() (+20.18%) | Filing History |
| 2022-02-14 08:41 am Purchase | 2021-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,921,579 8.400% | 498,724![]() (+14.57%) | Filing History |
| 2022-02-14 08:41 am Sale | 2021-12-31 | 13G | ITEOS THERAPEUTICS INC. ITOS | RTW INVESTMENTS LP | 2,353,015 6.700% | -409,776![]() (-14.83%) | Filing History |
| 2022-02-14 08:39 am Purchase | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 2,980,960 6.600% | 2,980,960![]() (New Position) | Filing History |
| 2022-02-14 08:22 am Purchase | 2021-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW INVESTMENTS LP | 3,866,872 9.500% | 1,795,463![]() (+86.68%) | Filing History |
| 2022-02-14 08:21 am Purchase | 2021-12-31 | 13G | TELA BIO INC TELA | RTW INVESTMENTS LP | 1,399,686 9.700% | 15,870![]() (+1.15%) | Filing History |
| 2022-02-14 08:20 am Unchanged | 2021-12-31 | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | RTW INVESTMENTS LP | 2,319,138 9.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:18 am Sale | 2021-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,013,601 9.700% | -450,000![]() (-18.27%) | Filing History |

